Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression.

Jose R Castillo-MancillaMary MorrowPeter W HuntSamuel R SchnittmanAndrew N PhillipsJason V BakerJessica E HabererMaria Joao JaneiroFilipa AragaoCal CohenNicholas MusinguziTodd T Brown Matthias Cavassini Tracy R GlassSergio Serrano-VillarSamantha MawhinneyMark J Siedner

Published in: Open forum infectious diseases (2023)

Modest gains in ART adherence could have clinical benefits beyond virologic suppression. Increasing ART adherence (eg, via an intervention or switch to long-acting ART) in PWH who remain virally suppressed despite incomplete adherence should be evaluated.

Keyphrases

human immunodeficiency virus
antiretroviral therapy
hiv infected
hiv positive
hiv infected patients
hiv aids
hepatitis c virus
randomized controlled trial
glycemic control
metabolic syndrome
insulin resistance
skeletal muscle